Join us as we explore the science behind RelaxPLX® and its role in supporting restful sleep and well-being.

Developed from seven years of research on Lemon verbena (Lippia citriodora) extracts, RelaxPLX®offers a multi-faceted approach to healthy living.
Its story began with a study in university athletes, where RelaxPLX® was clinically studied for its effects on relaxation and sleep quality.

With its natural botanical composition, RelaxPLX® is designed to support your body’s natural rhythm and promote restful nights.

400 mg

Recommended daily dosage

3

Clinical Studies

Promoting Restorative Sleep:

RelaxPLX® and Natural Melatonin Support*

A recent clinical study found that taking RelaxPLX® 1–2 hours before bedtime supported the body’s natural melatonin production.
The study observed 14.3% higher levels of naturally occurring melatonin compared to those in the placebo group (p<0.05), highlighting RelaxPLX®’s potential to contribute to restful sleep and circadian rhythm balance.

Pérez-Piñero S, et al. Nutrients. 2024; 16(10):1523

In a randomized, double-blind, placebo-controlled clinical study, adults with poor sleep quality (PSQI >5) and occasional stress (STAI >15) who took RelaxPLX® for 2 months showed a 62.5% improvement in PSQI scores, with statistically significant results compared to placebo (p < 0.05).*

Pérez-Piñero S, et al. Nutrients. 2024; 16(10):1523

Restful Nights for Women, Backed by Science

A clinical study published in Nutrients evaluated the effects of RelaxPLX® in adults with poor sleep quality (PSQI >5) and elevated occasional stress (STAI >15). Participants taking RelaxPLX® showed statistically significant improvements in PSQI scores, with particularly notable results among women.*

(Martínez-Rodriguez A et al (2022). Nutrients 14, 218)

A clinical study evaluated RelaxPLX® in adults with self-reported poor sleep quality. Using actigraphy to assess sleep parameters, the study observed statistically significant improvements compared to placebo.

Participants experienced a 28% reduction in sleep latency (time taken to fall asleep), a 3.3% increase in sleep efficiency, and a 26.4% decrease in wake time after sleep onset (WASO). These results suggest that RelaxPLX® may support improvements in multiple aspects of sleep quality in individuals experiencing occasional sleep difficulties.

Pérez-Piñero S, et al. Nutrients. 2024; 16(10):1523

Supporting Emotional Balance Naturally

RelaxPLX® and Cortisol Balance for Emotional Well-being*

In a randomized, double-blind, placebo-controlled clinical trial lasting 8 weeks and followed by a 4-week washout period, participants taking RelaxPLX® reported a reduction in perceived occasional stress. This was accompanied by a statistically significant difference in cortisol levels compared to placebo.

(Martínez-Rodriguez A et al (2022). Nutrients 14, 218)

Supporting Sleep Quality in adolescents

In a recent 12-week, double-blind, placebo-controlled study, adolescents aged 12–16 who took RelaxPLX® experienced a progressive improvement in sleep quality, as measured by the Adolescent Sleep Wake Scale (ASWS).

Benefits were observed as early as the first month, with improvements reaching up to +40% by week 12 compared to baseline.

Study population: N=42 healthy adolescents with sleep complaints.

(Navarro, P., et al. Applied Sciences. 2025, 15(11), 5856.)

Natural Solution for Adolescents' Emotional Wellbeing:

RelaxPLX® has been associated with benefits related to occasional stress in adolescents, starting in the first month and continuing through 12 weeks. Biomarker analysis showed a 21% shift in the experimental group vs. 8.9% in placebo.

Female participants showed the strongest response, with a 25% variation, supporting a link to mental well-being and a positive mental outlook.

Navarro, P., et al. Applied Sciences. 2025, 15(11), 5856.

This website is intended exclusively for professional clients in the health, pharmaceutical and food supplement sector and not for consumers. The products presented on the website are not intended to diagnose, treat, cure or prevent any disease. The compliance of a final product with the regulation and related claims in the country where it Will be sold, remain the responsability of the profesional client.